Novel mutations target distinct subgroups of medulloblastomaGiles Robinson, Richard J. Gilbertson, Lei Wei et al.|Nature|2012Cited by 853
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysisVijay Ramaswamy, Michael D. Taylor, Marc Remke et al.|The Lancet Oncology|2013Cited by 404
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M. Thompson, Tibor Hortobágyi, Thomas Hielscher et al.|The Lancet Oncology|2016Cited by 369
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort AnalysisVijay Ramaswamy, Ralph P. Ermoian, Thomas Hielscher et al.|Journal of Clinical Oncology|2016Cited by 206